PT-141: PT-141 (Bremelanotide)
Category: Melanocortin System
PT-141, also known as Bremelanotide, is a synthetic peptide that acts on the melanocortin receptor system. It was originally developed from Melanotan II and gained scientific attention because it works through central nervous system pathways rather than the vascular mechanisms used by traditional approaches. The FDA approved a commercial version under the brand name Vyleesi in 2019.
This guide compiles key literature themes, handling context, and practical comparison points for research-focused evaluation.
Overview
The peptide is notable in pharmacology because it represents a fundamentally different mechanism for addressing sexual dysfunction. Instead of acting on blood flow, PT-141 activates melanocortin-4 (MC4R) receptors in the brain. This central mechanism was first discovered serendipitously during research into skin pigmentation.
Discovery & Background
PT-141 emerged from the Melanotan research program at the University of Arizona in the 1990s. Researchers Mac Hadley and Victor Hruby were developing Melanotan II for tanning when they noticed unexpected effects on sexual function in study participants. This led to the development of PT-141 as a derivative specifically optimized for MC4R activation. Palatin Technologies later developed it through clinical trials, and it received FDA approval in 2019.
Mechanism of Action
PT-141 activates melanocortin-4 receptors in the central nervous system, a pathway distinct from PDE5 inhibitors. This central mechanism affects arousal pathways at the neurological level.
- 1Selectively activates melanocortin-4 (MC4R) receptors in the hypothalamus and limbic system
- 2Works through central nervous system pathways, not vascular mechanisms
- 3Stimulates dopaminergic activity in brain regions associated with arousal and motivation
- 4May activate melanocortin-3 receptors (MC3R) to a lesser degree
- 5Derived from alpha-MSH structure with modifications for receptor selectivity and stability
- 6Effects are neurologically mediated, distinguishing it from peripheral vasodilators
Research Benefits
The benefit areas below reflect commonly discussed research interests for this peptide.
Central Mechanism
Acts through brain-based melanocortin pathways rather than peripheral vascular mechanisms, a fundamentally different pharmacological approach.
FDA-Approved Derivative
Bremelanotide received FDA approval in 2019, indicating it passed rigorous clinical safety and efficacy evaluation.
Novel Pharmacology
First-in-class melanocortin receptor agonist approved for this indication, opening new research avenues.
Melanocortin Research
Valuable research tool for studying the broader melanocortin receptor system and its role in behavior and metabolism.
Published Research
RECONNECT Trials
Phase 3 trials showed statistically significant improvements in desire and reduction in distress scores compared to placebo.
Obstetrics & Gynecology, 2019
Central Mechanism
fMRI studies confirmed that PT-141 activates brain regions associated with arousal, confirming its central mechanism of action.
Journal of Sexual Medicine, 2008
Dose-Response
Optimal effects observed at 1.75mg subcutaneous dose, with onset of action within 30-60 minutes and effects lasting up to 12 hours.
Clinical Pharmacology & Therapeutics, 2016
Safety Profile
Most common side effects were nausea (40%), flushing (20%), and headache (11%). No serious cardiovascular events reported.
FDA Prescribing Information, 2019
Reported Side Effects & Considerations
- •Nausea is the most common side effect (40% in clinical trials), usually mild and transient
- •Flushing and headache reported in a subset of participants
- •Transient increases in blood pressure observed (contraindicated in uncontrolled hypertension)
- •May cause temporary skin darkening due to melanocortin activation
- •Not recommended for frequent use due to potential blood pressure effects
Storage Guidelines
Temperature
2-8C refrigerated
Once Reconstituted
Use within 14 days when refrigerated
Shelf Life
24 months lyophilized at -20C
Frequently Asked Questions
What is PT-141?
PT-141 (Bremelanotide) is a synthetic peptide that activates melanocortin-4 receptors in the brain. It was developed from Melanotan II research and received FDA approval as Vyleesi in 2019.
How does PT-141 differ from PDE5 inhibitors?
PT-141 works through central nervous system melanocortin receptors in the brain, while PDE5 inhibitors work by increasing blood flow through peripheral vascular mechanisms. They have completely different pharmacological targets.
What is the melanocortin system?
The melanocortin system is a group of receptors (MC1R through MC5R) and their peptide ligands that regulate skin pigmentation, appetite, energy homeostasis, and other physiological processes.
How was PT-141 discovered?
It was discovered serendipitously during research into Melanotan II for skin tanning at the University of Arizona. Researchers noticed unexpected effects and developed PT-141 as a targeted derivative.
What are the main research applications?
PT-141 is primarily used in melanocortin receptor research, neurological arousal pathway studies, and as a pharmacological tool for understanding MC4R signaling.
Research Disclaimer
This guide is for educational and informational purposes only. All information is based on published scientific research and peer-reviewed literature. Peptides sold by Peptrolix are intended solely for laboratory research use and are not for human consumption. Consult healthcare professionals before making any health decisions.
Shop PT-141
99%+ purity, lab-tested with certificate of analysis.
Review variant options and quantity pricing before adding to cart.
View PT-141Browse All PeptidesRelated Peptide Guides
Related searches:
- pt-141
- pt 141 peptide
- bremelanotide
- pt-141 research
- pt-141 mechanism
- melanocortin receptor agonist
- bremelanotide studies
- pt-141 clinical trials
Explore More Peptide Guides
Explore adjacent compounds to compare mechanisms, side-effect discussions, and study focus across related peptides.
Start Your Research Today
All peptides 99%+ purity with certificates of analysis.
Products from Peptrolix are supplied strictly for laboratory and scientific research use only.
Shop Peptides